Navigation Links
Pharmalink AB Raises SEK 35 Million Through Share Issue
Date:1/4/2012

STOCKHOLM, January 4, 2012 /PRNewswire/ --

Pharmalink AB, today announces it has raised SEK 35 million through a rights issue of new shares to the Company's existing shareholders, including Industrifonden.

The new funds will be used to further advance Nefecon® and Busulipo™, Pharmalink's two lead product candidates. Nefecon is the first pharmaceutical product especially developed for patients with IgA nephropathy, the most common form of primary glomerulonephritis and a cause of end-stage renal disease requiring treatment with dialysis or transplantation. Nefecon has shown positive results in an open-labeled Phase II trial evaluating safety and efficacy and Pharmalink is currently focusing on preparing pivotal clinical trials.

Busulipo is being developed to provide a best-in-class conditioning agent for use priorto hematopoietic stem cell transplantation (HSCT), also often known as bone marrow transplantation. Busulipo has successfully undergone Phase II clinical trials and extensive data on efficacy, safety and pharmacokinetics compare positively with historical controls. Pharmalink is currently preparing for late stage clinical trials and for the registration and introduction of Busulipo into key global markets.

Pharmalink's Managing Director Johan Häggblad said, "Pharmalink's ability to raise capital in the current difficult economic climate reflects the potential of our product pipeline and the confidence our shareholders have in our Company and strategy. Our two main product candidates have shown very promising results and this new funding will support their further progress towards becoming new medicines for important indications."

Lennart Hansson, Investment Director at Industrifonden and member of the Pharmalink Board said: "As part of Industrifonden's investment strategy, we are seeking to direct more significant capital to work in those companies we believe will deliver major successes. Pharmalink is ve
'/>"/>

SOURCE Pharmalink
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmalink AB Receives US Orphan Drug Designation for Nefecon(R) (PL-56)
2. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
3. Pharmalink AB Receives Patent for Nefecon(R) Principle
4. MacuCLEAR, Inc. Raises More Than $1M in Financing and Enters into Strategic Pacific Rim Partnership
5. Cohera Medical Raises Over $25 Million in Series C Round
6. ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease
7. arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round
8. Vista Partners Updates Coverage on Cellmid Limited; Raises Target Price to AUD $0.12
9. Bayer Virtual Walk for Hemophilia Raises Awareness and Funds for People With Bleeding Disorders
10. NxStage Reports Record Third Quarter 2011 Financial Results and Raises Revenue Guidance For 2011
11. FRC Praises House Committee for Holding Hearing on Conscience-Violating Obamacare Contraceptive Mandate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... TAMPA, Fla. , Sept. 17, 2014   ... announced today that Business Insurance magazine has ... Insurance" distinction for the third year in a row. ... joint effort of Business Insurance  and the Best ... evaluation, is open to all publicly or privately-held insurance ...
(Date:9/17/2014)... ANGELES and LEIPZIG, Germany ... today announced that it has entered into an ... the development of antibody-based imaging agents to image ... "Our collaboration with Novotectid expands ImaginAb,s capability to precisely ... immune-oncology and autoimmune disease areas. The ability to ...
(Date:9/17/2014)... PALO ALTO, Calif. , Sept. 17, 2014 /PRNewswire/ ... of the Company,s Phase 2 clinical program of NP001 ... Lou Gehrig,s disease) are being highlighted today ... of the ALS Research Group , being held in ... According to a  post hoc  analysis, administration of a ...
Breaking Medicine Technology:myMatrixx Honored with "Best Places to Work in Insurance" Award 2ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3
... Reportlinker.com announces that a new market research report ... Drug Delivery in Central Nervous System Diseases - ... The delivery of drugs ... in the treatment of neurological disorders. Drugs may ...
... Robbins & Myers, Inc. (NYSE: ... its Romaco businesses to a group of funds led ... investment firm.  Total consideration was approximately euro 65 million ... and euro 4 million of assumed liabilities and is ...
Cached Medicine Technology:Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 2Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 3Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 4
(Date:9/17/2014)... Vegas, NV (PRWEB) September 17, 2014 ... Dr. Dan Ritchie and Dr. Cody Sipe that is helping ... of life and longevity has caught the attention of Shane ... most people in their 50s, 60s, or even 70s what ... of life on a day-to-day basis, they would probably answer ...
(Date:9/17/2014)... these sound like the ideas of a science ... of an exciting new approach to imaging local ... metastatic prostate cancer, scientists at Virginia Commonwealth University ... and Johns Hopkins Medical Institutions have provided proof-of-principle ... revolutionize doctors, ability to see tumors that have ...
(Date:9/17/2014)... Tidewater Physical Therapy and ... for football players and their parents at its Newport ... open at 6:30 p.m. for athletes and parents to ... and physical therapists. The workshop will start at 7 ... News Tidewater Performance Center, which features sports performance and ...
(Date:9/17/2014)... University] As Congress adjourns this month for the ... step over on their way out the chamber door ... Medicare Provider Payment Modernization Act of 2014. In a ... Dr. Eli Adashi recounts what he and other advocates ... The perennial trouble with how Medicare pays doctors will ...
(Date:9/17/2014)... Toledo, Ohio (PRWEB) September 17, 2014 ... hearing for today, September 17, 2014, to consider: , ... Testosterone Replacement Therapy (TRT), and, 2. ... of TRT. , With the TRT litigation ongoing, an ... FDA on the dangers of testosterone replacement therapy. Among ...
Breaking Medicine News(10 mins):Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2
... to Meet HRPA,s Stringent Pricing ... and Transparency Requirements, INDIANAPOLIS, ... benefit management (PBM) subsidiary, has,received Transparency in Pharmaceutical Purchasing Solutions ... the certification will enable WellPoint NextRx to offer PBM services,to ...
... Stand for Safe ... Patient Care, OAKLAND, Calif., Oct. 10 ... begin a two-day,strike at 15 Northern California hospitals this morning in California,s,largest strike ... of the big Sutter health chain and include some of the,largest hospitals in ...
... YORK, Oct. 10 On Oct. 23rd, the fashion ... Sadove, Chairman,and CEO of Saks Fifth Avenue, at "Fresh ... Youth and Families, which will take place at,The Pierre ... will,feature a performance by Judy Collins. The event, which ...
... Corporation, an,orthopedic implants company focused on silicon nitride ... on the in-vitro,testing and evaluation of its silicon ... HAP Paul Award from the International Society for,Technology ... which,was presented to Amedica at ISTA,s 20th Annual ...
... Oct. 10 Synova Healthcare Group,Inc. (OTC Bulletin ... in,the National Association of Nurse Practitioners in Women,s ... the New Millennium." The,NPWH is the leading association ... will take place October 10 - 13, in ...
... VANCOUVER, Oct. 10 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) ... Center for,Colorectal Health in Chicago. The new Clinic ... The additional clinic increases CRH,s overall,patient appointment capacity ... protocol. Commenting on the Chicago expansion, Edward ...
Cached Medicine News:Health News:Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 2Health News:Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 3Health News:Two-Day Nurses Strike Begins Today 2Health News:Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 2Health News:Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 3Health News:Amedica's Silicon Nitride Ceramic Bearing Technology Receives Prestigious HAP Paul Award for Use in Total Hip Arthroplasty 2Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 2Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 3Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 4Health News:CRH Medical Corporation opens second clinic in Chicago 2
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
50L...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
Medicine Products: